Suppr超能文献

利福平微胶囊的制备与表征

Formulation and characterization of rifampicin microcapsules.

作者信息

Sarfaraz Md, Hiremath D, Chowdary K P R

机构信息

Department of Pharmaceutics, N. E. T. College of Pharmacy, Raichur-584 101, India.

出版信息

Indian J Pharm Sci. 2010 Jan;72(1):101-5. doi: 10.4103/0250-474X.62240.

Abstract

Rifampicin biodegradable microcapsules were prepared by feasible emulsification-ionic gelation method for a novel controlled release product. Sodium alginate and Carbopol 974P were used as coating polymers in different ratios 1:1, 1:2, 1:3 and 1:4 to obtain elegant microcapsules. The formulations were characterized for encapsulation efficiency, drug loading, sieve analysis, scanning electron microscopy and in vitro release studies. The microcapsules were discrete, large, almost spherical and free flowing with encapsulation efficiency in the range of 75% to 89%, drug loading 75% to 86% and size 440 mum to 500 mum. Rifampicin release from these microcapsules was slow and extended over longer periods of time depending on the polymer coat. Drug release was diffusion controlled and followed first order kinetics. The formulation MC1 with a coating ratio of 1:1 (Sodium alginate: Carbopol 974P) was found to be suitable for oral controlled release.

摘要

采用可行的乳化-离子凝胶法制备利福平可生物降解微胶囊,以获得新型控释产品。海藻酸钠和卡波姆974P以1:1、1:2、1:3和1:4的不同比例用作包衣聚合物,以制备外观良好的微胶囊。对制剂进行包封率、载药量、筛分分析、扫描电子显微镜和体外释放研究等表征。微胶囊呈离散状、较大、近乎球形且流动性良好,包封率在75%至89%之间,载药量在75%至86%之间,粒径在440μm至500μm之间。这些微胶囊中利福平的释放缓慢,且根据聚合物包衣情况在较长时间内持续释放。药物释放受扩散控制,符合一级动力学。发现包衣比例为1:1(海藻酸钠:卡波姆974P)的制剂MC1适用于口服控释。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a415/2883207/0922650a164e/IJPhS-72-101-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验